Jump to contentJump to search
Symbolbild Neurone im Raum

Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab.
Räuber et al., Front Immunol. 2022

Saskia Räuber, Alice Willison, Melanie Korsen, Tristan Kölsche, Kristin S Golombeck, Benedikt Plaack, Julia Schüller, Niklas Huntemann, Leoni Rolfes, Christina B Schroeter, Christopher Nelke, Liesa Regner-Nelke, Moritz Förster, Marius Ringelstein, Michael Harry Barnett, Hans-Peter Hartung, Orhan Aktas, Philipp Albrecht, Tobias Ruck, Nico Melzer, Sven G Meuth, David Kremer.

Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab.

Front Immunol. 2022 Dec 23;13:1037214. doi: 10.3389/fimmu.2022.1037214. eCollection 2022. PubMed ID: 36618356

 

Further Information:

PubMed

Hans-Peter Hartung

Orhan Aktas

Kategorie/n: NND-Publikationen
Responsible for the content: